The Professional Counselor | Volume 12, Issue 2 119 Gibson, T. B., Ozminkowski, R. J., & Goetzel, R. Z. (2005). The effects of prescription drug cost sharing: A review of the evidence. The American Journal of Managed Care, 11(11), 730–740. Gruenwald, J., Brendler, T., & Jaenicke, C. (2007). PDR for herbal medicines (4th ed.). Thomson Healthcare. Gureje, O., Nortje, G., Makanjuola, V., Oladeji, B. D., Seedat, S., & Jenkins, R. (2015). The role of global traditional and complementary systems of medicine in the treatment of mental health disorders. The Lancet Psychiatry, 2(2), 168–177. https://doi.org/10.1016/S2215-0366(15)00013-9 Guzmán Gutierrez, S. L., Reyes Chilpa, R., & Bonilla Jaime, H. (2014). Medicinal plants for the treatment of “nervios”, anxiety, and depression in Mexican traditional medicine. Revista Brasileira de Farmacognosia, 24(5), 591–608. https://doi.org/10.1016/j.bjp.2014.10.007 Hashiguchi, M., Ohta, Y., Shimizu, M., Maruyama, J., & Mochizuki, M. (2015). Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia. Journal of Pharmaceutical Health Care and Sciences, 1(1), 1–12. https://doi.org/10.1186/s40780-015-0014-7 He, S.-M., Chan, E., & Zhou, S.-F. (2011). ADME properties of herbal medicines in humans: Evidence, challenges and strategies. Current Pharmaceutical Design, 17(4), 357–407. https://doi.org/10.2174/138161211795164194 Hellbom, E. (2006). Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment. Medical Hypotheses, 66(4), 689–690. https://doi.org/10.1016/j.mehy.2005.12.006 Hendrickson, B. P., Shaikh, N., Occhiogrosso, M., & Penzner, J. B. (2016). Mania induced by Garcinia cambogia: A case series. The Primary Care Companion for CNS Disorders, 18(2). https://doi.org/10.4088/PCC.15l01890 Hoskins, D., & Padrón, E. (2018). The practice of Curanderismo: A qualititative study from the perspectives of Curandera/os. Journal of Latina/o Psychology, 6(2), 79–93. https://doi.org/10.1037/lat0000081 Ingersoll, R. E. (2005). Herbaceuticals: An overview for counselors. Journal of Counseling & Development, 83(4), 434–443. https://doi.org/10.1002/j.1556-6678.2005.tb00365.x Ingersoll, R. E., & Rak, C. F. (2016). Psychopharmacology for mental health professionals: An integrative approach (2nd ed.). Cengage. Julius, R. J., Novitsky, M. A., Jr., & Dubin, W. R. (2009). Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice, 15(1), 34–44. https://doi.org/10.1097/01.pra.0000344917.43780.77 Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002). Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA, 287(3), 337–344. https://doi.org/10.1001/jama.287.3.337 Kaut, K. (2011). Psychopharmacology and mental health practice: An important alliance. Journal of Mental Health Counseling, 33(3), 196–222. https://doi.org/10.17744/mehc.33.3.u357803u508r4070 Kaut, K. P., & Dickinson, J. A. (2007). The mental health practitioner and psychopharmacology. Journal of Mental Health Counseling, 29(3), 204–225. https://doi.org/10.17744/mehc.29.3.t670636302771120 Kladar, N., Anačkov, G., Srđenović, B., Gavarić, N., Hitl, M., Salaj, N., Jeremić, K., Babović, S., & Božin, B. (2020). St. John’s wort herbal teas – Biological potential and chemometric approach to quality control. Plant Foods for Human Nutrition, 75, 390–395. https://doi.org/10.1007/s11130-020-00823-1 LaFrance, W. C., Lauterbach, E. C., Coffey, C. E., Salloway, S. P., Kaufer, D. I., Reeve, A., Royall, D. R., Aylward, E., Rummans, T. A., & Lovell, M. R. (2000). The use of herbal alternative medicines in neuropsychiatry: A report of the ANPA Committee on Research. The Journal of Neuropsychiatry and Clinical Neurosciences, 12(2), 177–192. https://doi.org/10.1176/appi.neuropsych.12.2.177 Liao, Z., Cheng, L., Li, X., Zhang, M., Wang, S., & Huo, R. (2020). Meta-analysis of Ginkgo biloba preparation for the treatment of Alzheimer’s disease. Clinical Neuropharmacology, 43(4), 93–99. https://doi.org/10.1111/j.1468-1331.2006.01605.x Liu, Y., Lund, J. A., Murch, S. J., & Brown, P. N. (2018). Single-lab validation for determination of kavalactones and flavokavains in Piper methysticum (Kava). Planta Medica, 84(16), 1213–1218. https://doi.org/10.1055/a-0637-2400 Macneil, C. A., Hasty, M. K., Conus, P., & Berk, M. (2012). Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice. BMC Medicine, 10, Article 111. https://doi.org/10.1186/1741-7015-10-111 Makaryus, A. N., & Friedman, E. A. (2005). Patients’ understanding of their treatment plans and diagnosis at discharge. Mayo Clinic Proceedings, 80(8), 991–994. https://doi.org/10.4065/80.8.991
RkJQdWJsaXNoZXIy NDU5MTM1